In contrast, the higher proportion of patients with bleeding below 50% of the estimated volemia were among those who were not exposed to the drug p = 0.001. We do not describe differences for estimated losses less than 25%, 33% and 40% of the blood volume.
Por el contrario, la mayor proporción de pacientes que presentaron sangrado menor del 50% de la volemia calculada correspondió al grupo sin dicho medicamento p = 0,001; a su vez, tampoco describimos diferencias para pérdidas calculadas por debajo del 25, del 33 y del 40% de la volemia.